Cranswick (CWK) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
25 Nov, 2025Executive summary
Achieved strong revenue growth of 10.4% year-over-year, with like-for-like revenue up 7.9% and 7% volume growth in UK food.
Adjusted operating margin rose to 7.7%, supported by integrated poultry supply chain, automation, and cost control.
Record capital investment of £89m in H1, including major projects in Hull and new houmous and dips facility.
Integration of recent acquisitions (Blakemans, JSR Genetics, Fridaythorpe Mill) is ahead of expectations and delivering synergies.
Outlook for the full year remains in line with Board expectations, with positive trading momentum into Q3.
Financial highlights
Revenue: £1,468.3m (+10.4% year-over-year); like-for-like revenue up nearly 8%.
Adjusted operating profit increased 13.5% to £113m; adjusted PBT up 9.7% to £105.1m.
Adjusted EPS rose 9.3% to 144.4p per share; interim dividend increased 8% to 27.0p per share.
Free cash flow of £97m; free cash conversion at 89.9%; net debt (ex-leases) increased by £126.4m due to CapEx, acquisitions, and working capital build.
ROCE maintained at 18.2%; leverage at 0.4x (post IFRS 16: 0.9x).
Outlook and guidance
Christmas order book is strong, with record volumes expected for key products.
Full-year outlook remains in line with board expectations; operating margin expected to be maintained in H2.
Continued focus on quality, value, innovation, and customer service to drive future growth.
Ongoing investment in capacity and innovation expected to drive further growth.
Trading momentum continues into Q3, with strong demand for premium pork and poultry.
Latest events from Cranswick
- Record Christmas trading and strong Q3 growth drive profit outlook to upper market range.CWK
Q3 2026 TU27 Jan 2026 - Adjusted profit before tax up 17.4% on strong volume growth and margin expansion.CWK
H1 202512 Jan 2026 - Record revenue and margin growth, strong investment, and 35 years of dividend increases.CWK
H2 202519 Nov 2025 - Revenue up 9.7% year-over-year, with strong growth and positive outlook maintained.CWK
Q1 2026 TU28 Jul 2025 - Upgraded FY25 outlook driven by strong trading, volume growth, and ongoing investment.CWK
Trading Update13 Jun 2025 - Q1 revenue up 6.7% with strong UK demand and continued investment in capacity.CWK
Q1 2025 TU13 Jun 2025 - Record Q3 growth and JSR Genetics acquisition drive supply security and efficiency.CWK
Q3 2025 TU6 Jun 2025 - Upgraded targets and major investments drive growth in premium food categories and efficiency.CWK
CMD 20256 Jun 2025